...
首页> 外文期刊>PLoS Pathogens >The Pathogenic Mechanism of the Mycobacterium ulcerans Virulence Factor, Mycolactone, Depends on Blockade of Protein Translocation into the ER
【24h】

The Pathogenic Mechanism of the Mycobacterium ulcerans Virulence Factor, Mycolactone, Depends on Blockade of Protein Translocation into the ER

机译:溃疡分枝杆菌毒力因子分枝内酯的致病机制取决于蛋白转运进入内质网的阻断

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Infection with Mycobacterium ulcerans is characterised by tissue necrosis and immunosuppression due to mycolactone, the necessary and sufficient virulence factor for Buruli ulcer disease pathology. Many of its effects are known to involve down-regulation of specific proteins implicated in important cellular processes, such as immune responses and cell adhesion. We have previously shown mycolactone completely blocks the production of LPS-dependent proinflammatory mediators post-transcriptionally. Using polysome profiling we now demonstrate conclusively that mycolactone does not prevent translation of TNF, IL-6 and Cox-2 mRNAs in macrophages. Instead, it inhibits the production of these, along with nearly all other (induced and constitutive) proteins that transit through the ER. This is due to a blockade of protein translocation and subsequent degradation of aberrantly located protein. Several lines of evidence support this transformative explanation of mycolactone function. First, cellular TNF and Cox-2 can be once more detected if the action of the 26S proteasome is inhibited concurrently. Second, restored protein is found in the cytosol, indicating an inability to translocate. Third, in vitro translation assays show mycolactone prevents the translocation of TNF and other proteins into the ER. This is specific as the insertion of tail-anchored proteins into the ER is unaffected showing that the ER remains structurally intact. Fourth, metabolic labelling reveals a near-complete loss of glycosylated and secreted proteins from treated cells, whereas cytosolic proteins are unaffected. Notably, the profound lack of glycosylated and secreted protein production is apparent in a range of different disease-relevant cell types. These studies provide a new mechanism underlying mycolactone's observed pathological activities both in vitro and in vivo. Mycolactone-dependent inhibition of protein translocation into the ER not only explains the deficit of innate cytokines, but also the loss of membrane receptors, adhesion molecules and T-cell cytokines that drive the aetiology of Buruli ulcer.
机译:溃疡分枝杆菌的感染的特征在于组织坏死和免疫抑制,这归因于分枝杆菌内酯,这是布鲁氏溃疡病病理学的必要和充分的毒力因子。已知其许多作用涉及下调重要细胞过程中涉及的特定蛋白质,例如免疫反应和细胞粘附。先前我们已经证明,mycolactone可以在转录后完全阻断LPS依赖性促炎性介质的产生。现在,使用多核糖体分析,我们最终证明了Mycolactone不会阻止巨噬细胞中TNF,IL-6和Cox-2 mRNA的翻译。取而代之的是,它抑制了这些蛋白以及几乎所有其他穿过ER的其他蛋白(诱导型和组成型)的产生。这是由于蛋白质移位的阻止和异常定位蛋白质的随后降解。有几条证据支持对霉菌内酯功能的这种转化性解释。首先,如果同时抑制26S蛋白酶体的作用,则可以再次检测细胞TNF和Cox-2。其次,在胞质溶胶中发现了恢复的蛋白质,表明无法移位。第三,体外翻译实验表明,mycolactone可以阻止TNF和其他蛋白质向ER的转运。这是特定的,因为尾部锚定蛋白插入ER不受影响,表明ER在结构上保持完整。第四,代谢标记揭示了糖基化和分泌蛋白从处理过的细胞中几乎完全丢失,而胞质蛋白不受影响。值得注意的是,在一系列与疾病相关的不同细胞类型中,明显缺乏糖基化和分泌蛋白的产生。这些研究提供了新的机制,在体外和体内都可检测到Mycolactone的病理活性。 Mycolactone依赖于蛋白质转运进入ER的抑制作用不仅解释了先天细胞因子的缺乏,而且解释了驱动Buruli溃疡病因的膜受体,粘附分子和T细胞细胞因子的损失。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号